[Comment on the information by the Federal Drug and Medical Products Institute on "calcium channel blockers of the 1,4-dihydropyridine class"]

Internist (Berl). 1995 Jul;36(7):730-1.

[Article in German]

Author

P Trenkwalder¹

Affiliation

¹ Medizinische Klinik, Krankenhaus des Landkreises Starnberg.

PMID: 7672923

No abstract available

MeSH terms

Calcium Channel Blockers / adverse effects*
Calcium Channel Blockers / therapeutic use
Coronary Disease / chemically induced*
Coronary Disease / drug therapy
Delayed-Action Preparations
Dihydropyridines / adverse effects*
Dihydropyridines / therapeutic use
Drug Approval / legislation & jurisprudence*
Germany
Humans
Hypertension / drug therapy*
Structure-Activity Relationship

Substances

Calcium Channel Blockers
Delayed-Action Preparations
Dihydropyridines
1,4-dihydropyridine